These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3432126)

  • 1. The effect of AVP and DGAVP on the exploratory activity of rats.
    Skopková J; Lát J; Dvorská I; Hrbas P; Radil T
    Peptides; 1987; 8(5):785-90. PubMed ID: 3432126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of ethanol tolerance by desglycinamide-arginine-vasopressin occurs in the absence of changes in hippocampal serotonin synthesis.
    Speisky MB; Kalant H
    Alcohol Alcohol Suppl; 1987; 1():455-9. PubMed ID: 3426715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin-like peptides retain ethanol tolerance in the absence of changes in serotonin synthesis in limbic structures.
    Speisky MB; Kalant H
    Pharmacol Biochem Behav; 1986 Oct; 25(4):797-803. PubMed ID: 2431418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M; De Wied D
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of desglycinamide-(Arg8)-vasopressin (DGAVP) on the acquisition of free-choice alcohol drinking in rhesus monkeys.
    Kornet M; Goosen C; Ribbens LG; Van Ree JM
    Alcohol Clin Exp Res; 1991 Feb; 15(1):72-9. PubMed ID: 2024735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task.
    Vawter MP; De Wied D; Van Ree JM
    Neuropeptides; 1997 Oct; 31(5):489-94. PubMed ID: 9413027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats.
    Sahgal A
    Psychopharmacology (Berl); 1987; 93(2):243-9. PubMed ID: 3122257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin(1-8) (des-glycinamide9-[Arg8]vasopressin) is an endogenous peptide present in rat plasma.
    Laczi F; Burbach JP; Van der Kleij AA; De Wied D; Wiegant VM
    Peptides; 1991; 12(2):329-32. PubMed ID: 2067985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats.
    van Ree JM; Burbach-Bloemarts EM; Wallace M
    Life Sci; 1988; 42(10):1091-9. PubMed ID: 3347140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior.
    Skopkova J; Croiset G; De Wied D
    Peptides; 1991; 12(3):471-5. PubMed ID: 1923926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater task difficulty amplifies the facilitatory effect of des-glycinamide arginine vasopressin on appetitively motivated learning.
    Messing RB; Sparber SB
    Behav Neurosci; 1985 Dec; 99(6):1114-9. PubMed ID: 3843542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of DGAVP in plasma following intranasal and oral administration to healthy subjects.
    Westenberg HG; Hijman R; Wiegant VM; Laczi F; Van Ree JM
    Peptides; 1994; 15(6):1101-4. PubMed ID: 7991455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats.
    Sahgal A
    Behav Brain Res; 1988 Jul; 29(1-2):35-42. PubMed ID: 3401320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
    Ang VT; Jenkins JS
    J Endocrinol; 1982 Jun; 93(3):319-25. PubMed ID: 7086325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.
    Sahgal A
    Psychopharmacology (Berl); 1986; 90(4):494-8. PubMed ID: 3101105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats.
    Popik P; Wolterink G; De Brabander H; van Ree JM
    Physiol Behav; 1991 Jun; 49(6):1031-5. PubMed ID: 1896485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate.
    Verhoef J; van den Wildenberg HM; van Nispen JW
    J Endocrinol; 1986 Sep; 110(3):557-62. PubMed ID: 3760747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.